Amedisys, Inc. (AMED) Tops Q2 EPS by 3c; Guides FY12 EPS, Revs
Tweet Send to a Friend
Amedisys, Inc. (NASDAQ: AMED) reported Q2 EPS of $0.27, $0.03 better than the analyst estimate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
